SynGenSys applies computational design strategies to engineer synthetic promoters with predictable performance characteristics for therapeutic and manufacturing applications. Professor David James ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...

Scientists have uncovered a surprising secret about our DNA: it’s not a static blueprint, but a constantly shifting, folding ...

Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one ...

Stepping away from its billions-of-years-old role as a genetic blueprint, DNA is now embarking on a new journey as an active ...

Leucine-rich repeat kinase 2 (LRRK2) has emerged as a critical player in both neurological and peripheral diseases. In a ...

Public confidence in regulation demands that complaints are handled transparently and judged on evidence alone, write Rubin ...

How does alcohol change your brain at a genetic level? A new study reveals that alcohol metabolites directly alter epigenetic ...

FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission -- 30-patient pivotal study initiated, evaluating seizure reduction and ...